Concepedia

Author

Zhenyu Li

Xuzhou Medical CollegeORCID

Also Known As

Li Zhen-yu#, Li Zhenyu, Qingyun Wu, Ruiqi Tan, ZHen-Yu Li, Zhen-Yu Li, Zhen-yu Li, Zhenyu Li, Zhenyu Li (295387)

150

Publications

3.1K

Citations

27

H-Index

68

Concepts

All Affiliations

Xuzhou Medical CollegeAffiliated Hospital of Xuzhou Medical CollegeSoochow UniversityTongji HospitalAffiliated Hospital of Jiangsu University
ZL

About

Zhenyu Li is an author at Xuzhou Medical College specializing in medicine, immunology, and autoimmunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

732

2

Health Sciences

2

2

375

3

Nursing

1

1

65

4

Public Health

1

1

65

5

Allergy

1

1

37

Zhenyu Li

×

48

Publications

2.8K

Citations

26

H-Index

YearCitations

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019

Tao Liu, Jieying Zhang, Yuhui Yang,

EMBO Molecular Medicine

2020

405

A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial

Zhiling Yan, Jiang Cao, Hai Cheng,

The Lancet Haematology

2019

310

Potent anti‐leukemia activities of humanized CD19‐targeted Chimeric antigen receptor T (CAR‐T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

Jiang Cao, Gang Wang, Hai Cheng,

American Journal of Hematology

2018

170

SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer

Neha Kabra, Zhenyu Li, Lihong Chen,

Journal of Biological Chemistry

2009

154

Transcriptome Analysis of Chlorantraniliprole Resistance Development in the Diamondback Moth Plutella xylostella

Q. Lin, Fengliang Jin, Hu Zhendi,

PLoS ONE

2013

118

Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer’s disease via modulating the expression of miR-106b

Wenzhong Huang, Zhenyu Li, Liandong Zhao,

Biomedicine & Pharmacotherapy

2017

111

Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

Ying Wang, Chunrui Li, Jieyun Xia,

Blood Advances

2021

93

Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies

Ying Wang, Kunming Qi, Hai Cheng,

Biology of Blood and Marrow Transplantation

2019

91

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Yuekun Qi, Mingfeng Zhao, Yongxian Hu,

Blood

2022

88

Anti–G Protein–Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial

Jieyun Xia, Hujun Li, Zhiling Yan,

Journal of Clinical Oncology

2023

85

Page 1